允英生物

Allin Biotech (Shanghai Yunying Medical Technology) is a precision medicine company specializing in high-throughput molecular diagnostics and liquid biopsy technologies. The company focuses on the development and commercialization of next-generation sequencing (NGS) panels and PCR-based kits for cancer screening, companion diagnostics, and minimal residual disease (MRD) monitoring. Allin Biotech operates a CAP-certified and CLIA-compliant laboratory, providing comprehensive genomic profiling services to clinical and pharmaceutical partners. Their proprietary Allin-Seq platform integrates advanced molecular biology with bioinformatics to deliver high sensitivity in detecting low-frequency mutations in circulating tumor DNA (ctDNA). Headquartered in Shanghai, the company aims to advance personalized oncology treatment through innovative diagnostic solutions.